OrganoTherapeutics Company
OrganoTherapeutics use mini-brains for the discovery and development of effective drug candidates targeting Parkinson’s disease.
.png)
Industry:
Clinical Development
Headquarters:
Esch-sur-alzette, Luxembourg, Luxembourg
Last Funding Date:
2020-10-21
Last Funding Type:
Non-equity Assistance
Employee Number:
1-10
Investors Number:
2.0
Founded Date:
2019-01-01